Nucelion Therapeutics, VeGen Bio Partner on CAR-T Therapy The Story: Nucelion Therapeutics and VeGen Bio have partnered to transfer technology and manufacture VL-2511, a Phase II dual-target CAR-T the...
Key Highlights: Implications: Nucelion and VeGen Bio’s partnership could strengthen India’s domestic CAR-T manufacturing ecosystem by combining dual-target therapy development with G...
